Companies researching REVLIMID (lenalidomide)

Lenalidomide, marketed as REVLIMID, is a drug used to treat conditions such as myelodysplastic syndrome, multiple myeloma, and mantle cell lymphoma.

List of companies that research REVLIMID (lenalidomide)

CompanyCountryIndustryEmployeesRevenueTechnologies
Country flag

United States

Pharmaceutical Manufacturing

39k

$46B

REVLIMID (lenalidomide)

Country flag

United States

Hospitals and Health Care

12k

$2.4B

REVLIMID (lenalidomide)

Country flag

Canada

Hospitals and Health Care

5k

REVLIMID (lenalidomide)

Country flag

United States

Business Consulting and Services

20k

$2.9B

REVLIMID (lenalidomide)

Country flag

Czech Republic

Pharmaceutical Manufacturing

4.7k

$528M

REVLIMID (lenalidomide)

Showing top companies out of 9 that research REVLIMID (lenalidomide). Get the full list on TheirStack.

Frequently asked questions